Please assess the completion status of the following clinical trial:

Trial Title: Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Stage I-III breast cancer or Stage I-III NSCLC who are currently in active treatment or have completed initial cancer directed treatments (surgery, radiation, chemotherapy) within the past 3 months;~* Are experiencing at least moderate anxiety (GAD-7 \>10) or mild-to-moderate depression (PHQ-8 score 5-11);~* Are fluent in English; and~* Have access to smartphone, or tablet capable of running iOS or Android software.~Exclusion Criteria:~* Previous history of cancer;~* \<2-yr survival prognosis as determined by treating clinician;~* Currently participating in investigative CBT trial for treatment of anxiety or depression;~* Participant is unable to complete training, has cognitive deficits, more severe psychiatric conditions, lack of access to internet accessible device or psycho-social conditions (e.g., other social conditions, that would interfere with adherence to self-directed care), such that in investigator's opinion the participant would be unable to complete the study;~* Recently completed use of Blue Note Therapeutics Covid Cancer Care Program or other Blue Note Therapeutics-sponsored study; and~* PHQ-9 Q9 response \>0 AND Columbia Suicide Severity Risk Scale (or equivalent) score of Category 2- suicidal ideation at screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Attune™ (Type: ACTIVE_COMPARATOR): Attune™ is a completely digital, 10-session, cognitive behavioral therapeutic intervention.
- Cerena™ (Type: ACTIVE_COMPARATOR): Cerena™ is a completely digital, 10-session, health education and wellness intervention.

Based on this trial design, predict the completion outcome and termination type (if applicable).